Literature DB >> 6253196

Three new types of viral oncogenes in defective avian leukemia viruses. II. Biological, genetic, and immunochemical evidence.

T Graf, H Beug, A von Kirchbach, M J Hayman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6253196     DOI： 10.1101/sqb.1980.044.01.133

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  6 in total

1.  Characterization of mouse cellular deoxyribonucleic acid homologous to Abelson murine leukemia virus-specific sequences.

Authors:  B Dale; B Ozanne
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  Mutant of avian erythroblastosis virus defective for erythroblast transformation: deletion in the erb portion of p75 suggests function of the protein in leukemogenesis.

Authors:  H Beug; G Kitchener; G Doederlein; T Graf; M J Hayman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

3.  Isolation and biochemical characterization of partially transformation-defective mutants of avian myelocytomatosis virus strain MC29: localization of the mutation to the myc domain of the 110,000-dalton gag-myc polyprotein.

Authors:  G M Ramsay; M J Hayman
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

4.  Characterization of the oncogene (erb) of avian erythroblastosis virus and its cellular progenitor.

Authors:  S Saule; M Roussel; C Lagrou; D Stehelin
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

5.  Myeloblasts transformed by the avian acute leukemia virus E26 are hormone-dependent for growth and for the expression of a putative myb-containing protein, p135 E26.

Authors:  H Beug; M J Hayman; T Graf
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

6.  Phosphorylation of specific sites in the gag-myc polyproteins encoded by MC29-type viruses correlates with their transforming ability.

Authors:  G Ramsay; M J Hayman; K Bister
Journal:  EMBO J       Date:  1982       Impact factor: 11.598
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.